
Hello.
Welcome to BioFocus.
Explore the latest updates from the life science industry.

Popular Content.
Intuitive surpasses 10,000 robotic-assisted bronchoscopy procedures across Europe with Ion system
More than 10,000 robotic-assisted bronchoscopy procedures have now been performed across Europe using Intuitive’s Ion endoluminal system, marking a milestone in the adoption of technology designed to help clinicians access and biopsy difficult-to-reach lung nodules.
Featured Articles.
Latest News.
12th November, 2026
01.
PlaqueTec’s BIOPATTERN trial reaches 100 patients as NHS network expands to eight cardiac centres
Cambridge-based medtech company PlaqueTec has recruited the 100th participant into its BIOPATTERN clinical trial, which aims to uncover the biological mechanisms driving coronary artery disease and support the development of more personalised treatments. The trial has also expanded its network to eight NHS specialist cardiac centres across England.

11th November, 2026
02.
T-Cypher Bio expands into purpose-built laboratory space at Abingdon Science Park
Oxford-based biotechnology company T-Cypher Bio has relocated its headquarters to a newly built 12,000 sq ft facility at Abingdon Science Park, providing additional laboratory capacity as it advances its pipeline of T cell engager therapies.

10th November, 2026
03.
£30m venture philanthropy fund launched to accelerate development of new myeloma treatments
The DFN Foundation and philanthropist David Forbes-Nixon OBE have committed £15 million towards a new £30 million venture philanthropy fund, aimed at supporting early-stage biotech ventures developing potential treatments, diagnostics and technologies for myeloma.

5th November, 2026
04.
Intuitive surpasses 10,000 robotic-assisted bronchoscopy procedures across Europe with Ion system
More than 10,000 robotic-assisted bronchoscopy procedures have now been performed across Europe using Intuitive’s Ion endoluminal system, marking a milestone in the adoption of technology designed to help clinicians access and biopsy difficult-to-reach lung nodules.

Our Partners.

























